Sex-specific aspects of epidemiology, molecular genetics and outcome: primary brain tumours.
Recent years have seen a great interest in sex-specific aspects of many diseases, including cancer, in part because of the assumption that females have often not been adequately represented in early drug development and determination of safety, tolerability and efficacy in clinical trials. Brain tumours represent a highly heterogeneous group of neoplastic diseases with strong variation of incidence by age, but partly also by sex. Most gliomas are more common in men whereas meningiomas, the most common primary intracranial tumours, are more common in females. Potential sex-specific genetic risk factors and specific sex biology have been reported in a tumour-specific manner. Several small studies have indicated differences in tolerability and safety of, as well as benefit from, treatment by sex, but no conclusive data have been generated. Exploring sex-specific aspects of neuro-oncology should be studied more systematically and in more depth in order to uncover the biological reasons for known sex differences in this disease.
['Le Rhun|Emilie|E|', 'Weller|Michael|M|']
D001932:Brain Neoplasms D005260:Female D005910:Glioma D006801:Humans D008297:Male D008577:Meningeal Neoplasms D008579:Meningioma D017720:Molecular Epidemiology
female sex glioma meningioma male